Exceptional response to MEK inhibition in a patient with RAF1-Mutant myxofibrosarcoma: case report and mechanistic overview

Simple item page
dc.contributor.coauthorÖzgü, E.
dc.contributor.coauthorAydin, E.
dc.contributor.coauthorAdibi, A.
dc.contributor.coauthorTokat, Ü.M.
dc.contributor.coauthorTutar, O.
dc.contributor.coauthorHu, J.
dc.contributor.coauthorKurzrock, R.
dc.contributor.coauthorDemiray, M.
dc.contributor.departmentDepartment of Molecular Biology and Genetics
dc.contributor.kuauthorDemiray, İrem
dc.contributor.kuprofileUndergraduate Student
dc.contributor.schoolcollegeinstituteCollege of Sciences
dc.date.accessioned2025-01-19T10:30:11Z
dc.date.issued2023
dc.description.indexedbyWoS
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.volume7
dc.identifier.doi10.1200/PO.23.00299
dc.identifier.eissn2473-4284
dc.identifier.quartileQ1
dc.identifier.urihttps://doi.org/10.1200/PO.23.00299
dc.identifier.urihttps://hdl.handle.net/20.500.14288/26006
dc.identifier.wos1208474300001
dc.languageen
dc.publisherLippincott Williams & Wilkins
dc.sourceJCO Precision Oncology
dc.subjectOncology
dc.titleExceptional response to MEK inhibition in a patient with RAF1-Mutant myxofibrosarcoma: case report and mechanistic overview
dc.typeJournal Article

Files

Collections

Publications without Fulltext